Login

Biju Kulathakal, CEO and Co-Founder of Halo Investing, displays a sign at the office entrance stating "Impact Over Everything" to emphasize the company's core value. 00:10:00

Share On Facebook Share On Twitter

David Parker · CEO at Halo Security

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Leading a Company Through Financial Turbulence and Regulatory Scrutiny | Edison Garcia, CEO, Companhia Energetica de Brasilia.
00:10:00
Highcroft Mining's Unprecedented Silver Discovery and Expansion Plans for 2024
00:10:00
Data Respons Hackathon 2023 | Kenneth Ragnvaldsen, CEO, Data Respons ASADAT:OSL
00:10:00
Childhood Memories and Sibling Bonds|Madison Farkas,Professor,University of Wisconsin
00:10:00
Advancing TMG's Mount Peake Project Towards Production Milestones
00:10:00
Investment vehicle to empower historically overlooked people|Serena Williams,CEO,Serena Ventures
00:10:00
CDL is a no-fee/no-equity organization that delivers a 9-month objectives-based mentoring program|Sonia Sennik,Executive Director,Creative Destruction Lab
00:10:00
Webinar: Recent Developments at Peak Rare Earths
00:10:00
SolGold's Cascabel Project: Exploring Rich Porphyry Copper-Gold Systems in Ecuador
00:10:00
2025 Final Rule & AEP Updates Explained | Bob Bryszki, VP of Marketing, and Rob Valincius, Director of Agent Training at Pinnacle Financial Services
00:00:00
Cynata Therapeutics (ASX:CYP) CEO & MD Kilian Kelly
00:10:00
The Impact of Technology and Pro Bono on the Future of Law Practice

© 2017 - Neuhu+